Study of People With Generalized Arterial Calcification of Infancy (GACI) or Autosomal Recessive Hypophosphatemic Rickets Type 2 (ARHR2)
CompletedOBSERVATIONAL
Enrollment
48
Participants
Timeline
Start Date
April 17, 2018
Primary Completion Date
December 31, 2020
Study Completion Date
December 31, 2020
Conditions
Generalized Arterial Calcification of InfancyAutosomal Recessive Hypophosphatemic Rickets Type2
Trial Locations (1)
20892
National Institutes of Health Clinical Center, Bethesda
All Listed Sponsors
lead
National Human Genome Research Institute (NHGRI)
NIH
NCT03478839 - Study of People With Generalized Arterial Calcification of Infancy (GACI) or Autosomal Recessive Hypophosphatemic Rickets Type 2 (ARHR2) | Biotech Hunter | Biotech Hunter